Search Orphan Drug Designations and Approvals
-
Generic Name: | umbralisib in combination with ublituximab |
---|---|
Date Designated: | 01/05/2017 |
Orphan Designation: | Treatment of chronic lymphocytic leukemia |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 08/18/2023 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
TG Therapeutics, Inc. 343 Thornall Street, Suite 740 Edison, New Jersey 08837 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-